Vericel Corporation
We develop, manufacture and sell MACI, an autologous cultured chondrocyte transplant using a porcine collagen membrane, and Epicel, an autologous cultured epidermal transplant, for the treatment of burns and cell therapy used in sports medicine. Effective in treating knee cartilage damage and burns.
Overview
Overview | |
|---|---|
Country | United States |
State | Massachusetts |
Employees | 314 |
Founded | 1989 |
Financials | |
|---|---|
Market Capitalization | 2.36B |
Revenue | 207.78M |
Operating Income | -3.75M |
Operating Margin | -1.81% |
Net Income | 0.45M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 3260 / 5373 |
Sector : Healthcare | 243 / 1144 |
Industry : Biotechnology | 45 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 1817 / 5565 |
Sector : Healthcare | 214 / 1182 |
Industry : Biotechnology | 71 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 2856 / 5436 |
Sector : Healthcare | 202 / 1164 |
Industry : Biotechnology | 39 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 3248 / 5330 |
Sector : Healthcare | 382 / 1174 |
Industry : Biotechnology | 91 / 667 |